Literature DB >> 10540844

[Primary ciliary dyskinesia treated with living-donor lobar lung transplantation].

H Yamamoto1, K Kubo, N Nishizawa, Y Shiba, T Kaneki, T Koizumi, M Sekiguchi, S Eda, K Orii.   

Abstract

We report a case of primary ciliary dyskinesia in which a living-donor lobar lung transplant was performed. A 24-year-old woman with a diagnosis of primary ciliary dyskinesia and bronchiectasis was admitted to Shinshu University Hospital because of persistent dyspnea and pyrexia over a period of 4 months. Although she was given various antibiotics, neutrophilia, elevated plasma C-reactive protein (CRP) levels, and respiratory failure persisted. Chest roentgenograms and computed tomography disclosed severe bronchiectasis and diffuse infiltrative shadows in both lung fields. Pseudomonas aeruginosa was detected in a sputum culture. Although a variety of conventional therapies were administered, the patient's oxygenation progressively deteriorated. She was intubated and assisted by mechanical ventilation. The patient and her family proposed lung transplantation, and we concluded that a living-donor lobar lung transplant would be a suitable treatment for her disease. We transported the patient to Okayama University Hospital by helicopter 10 days after intubation. A living-donor lobar lung transplant was successfully performed with lung tissues donated by the patient's mother and sister for each transplant site.

Entities:  

Mesh:

Year:  1999        PMID: 10540844

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  1 in total

1.  Twenty-year Follow-up of the First Bilateral Living-donor Lobar Lung Transplantation in Japan.

Authors:  Masamichi Komatsu; Hiroshi Yamamoto; Toshitaka Shomura; Kei Sonehara; Takashi Ichiyama; Kazuhisa Urushihata; Atsuhito Ushiki; Masanori Yasuo; Toshihide Wakamatsu; Seiichiro Sugimoto; Takahiro Oto; Hiroshi Date; Tomonobu Koizumi; Masayuki Hanaoka; Keishi Kubo
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.